Table 2.
Age- and Multivariable-Adjusted Relative Risks for Incident Vertebral Fracture According to Diuretic Use*
| Thiazide Use | ||
| No | Yes | |
| Cases of Vertebral Fracture (n) | 316 | 104 |
| Person-years (n) | 451,178 | 92,032 |
| Age-adjusted Relative Risk (95% CI) | 1.0 | 1.44 (1.16, 1.80) |
| Multivariate Relative Risk (95% CI) † | 1.0 | 1.47 (1.18, 1.85) |
| Furosemide Use | ||
| No | Yes | |
| Cases of Vertebral Fracture (n) | 382 | 38 |
| Person-years (n) | 521,248 | 21,961 |
| Age-adjusted Relative Risk (95% CI) | 1.0 | 1.63 (1.16, 2.28) |
| Multivariate Relative Risk (95% CI) † | 1.0 | 1.59 (1.12, 2.25) |
Thiazide and furosemide use were updated throughout the analysis period (2002–2012). Relative risks are for the risk of vertebral fracture compared with the group that did not use diuretics.
The multivariate model includes: body mass index, race, physical activity, history of falls, smoking status, alcohol intake, supplemental calcium intake, quintiles of diet calcium intake, total vitamin D intake, vitamin A intake, total protein intake, self-reported diabetes or osteoporosis, history of beta-blocker use, bisphosphonate use, oral steroid use, or postmenopausal hormone use, and recent physical exam.